Faes Farma S.A. | Large-cap | Healthcare
€4.22
-0.47%
| Faes Farma S.A Stock Comparison:
Faes Farma S.A vs LaboratoriosFaes Farma S.A vs Almirall S.AFaes Farma S.A vs Laboratorio ReigFaes Farma S.A vs Labiana Health S.AFaes Farma S.A vs Grifols, S.AFaes Farma S.A vs IBEX 35 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2024

Income Metrics

Revenue 134.6M
Gross Profit 93.3M 69.26%
Operating Income 42.6M 31.63%
Net Income 27.9M 20.69%

Balance Sheet Metrics

Total Assets 1.0B
Total Liabilities 270.1M
Shareholders Equity 730.0M
Debt to Equity 0.37

Cash Flow Metrics

Revenue & Profitability Trend

Faes Farma S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i493.6M451.2M438.8M398.6M380.2M
Cost of Goods Sold i167.1M154.0M156.7M146.2M140.4M
Gross Profit i326.5M297.1M282.0M252.4M239.8M
Gross Margin % i66.1%65.9%64.3%63.3%63.1%
Operating Expenses
Research & Development i5.8M5.2M3.7M3.9M3.2M
Selling, General & Administrative i65.8M57.4M52.5M49.3M41.2M
Other Operating Expenses i35.0M35.8M35.0M27.4M34.9M
Total Operating Expenses i106.5M98.4M91.2M80.6M79.4M
Operating Income i110.1M103.7M102.2M97.8M92.6M
Operating Margin % i22.3%23.0%23.3%24.5%24.3%
Non-Operating Items
Interest Income i1.7M1.1M253.0K23.0K156.0K
Interest Expense i433.0K383.0K263.0K216.0K266.0K
Other Non-Operating Income-----
Pre-tax Income i107.6M102.9M101.4M93.0M84.9M
Income Tax i-3.5M11.2M12.0M10.5M11.5M
Effective Tax Rate % i-3.3%10.8%11.8%11.3%13.6%
Net Income i111.1M91.7M89.4M82.4M73.4M
Net Margin % i22.5%20.3%20.4%20.7%19.3%
Key Metrics
EBITDA i131.0M123.3M121.3M114.7M105.6M
EPS (Basic) i€0.36€0.30€0.28€0.27€0.25
EPS (Diluted) i€0.36€0.30€0.28€0.26€0.24
Basic Shares Outstanding i311248691306340000317403692302670130290618676
Diluted Shares Outstanding i311248691306340000317403692302670130290618676

Income Statement Trend

Faes Farma S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i64.2M34.6M66.4M70.3M91.2M
Short-term Investments i7.9M13.1M17.7M3.2M1.9M
Accounts Receivable i111.0M104.1M101.6M102.1M99.2M
Inventory i141.6M128.7M114.0M106.5M91.1M
Other Current Assets-----
Total Current Assets i333.7M290.3M313.2M293.7M290.0M
Non-Current Assets
Property, Plant & Equipment i1.5M61.5M59.6M2.2M2.4M
Goodwill i240.7M240.3M230.5M236.1M218.2M
Intangible Assets i127.6M128.1M126.9M129.4M112.9M
Long-term Investments-----
Other Non-Current Assets---4.0K-
Total Non-Current Assets i519.4M485.7M413.9M351.4M291.5M
Total Assets i853.1M776.0M727.2M645.1M581.5M
Liabilities
Current Liabilities
Accounts Payable i46.8M35.4M36.6M37.9M42.0M
Short-term Debt i20.1M19.5M28.3M14.3M12.2M
Current Portion of Long-term Debt-----
Other Current Liabilities----59.0K
Total Current Liabilities i103.5M86.8M94.4M79.3M84.7M
Non-Current Liabilities
Long-term Debt i2.7M4.4M4.4M2.2M1.6M
Deferred Tax Liabilities i15.6M16.9M21.1M21.7M17.4M
Other Non-Current Liabilities-241.0K35.0K157.0K687.0K
Total Non-Current Liabilities i23.0M25.9M30.3M28.5M24.0M
Total Liabilities i126.5M112.7M124.7M107.8M108.6M
Equity
Common Stock i31.6M31.6M31.1M29.7M28.5M
Retained Earnings i209.0M165.8M147.5M127.0M104.3M
Treasury Stock i11.0M11.0M5.3M5.3M5.3M
Other Equity-----
Total Shareholders Equity i726.6M663.3M602.4M537.3M472.9M
Key Metrics
Total Debt i22.9M23.9M32.7M16.4M13.9M
Working Capital i230.3M203.5M218.8M214.4M205.3M

Balance Sheet Composition

Faes Farma S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i111.1M91.7M89.4M82.4M73.4M
Depreciation & Amortization i-----
Stock-Based Compensation i747.0K774.0K146.0K0-
Working Capital Changes i-21.5M-12.3M-9.9M-14.7M-32.2M
Operating Cash Flow i90.0M79.6M79.6M67.9M41.3M
Investing Activities
Capital Expenditures i-33.7M-95.8M-68.0M-51.1M-19.8M
Acquisitions i0-4.5M0-22.6M0
Investment Purchases i-7.8M-8.8M-21.5M-1.9M-600.0K
Investment Sales i13.1M18.2M2.8M--
Investing Cash Flow i-36.2M-90.9M-86.7M-75.6M-20.4M
Financing Activities
Share Repurchases i0-17.7M00-92.0K
Dividends Paid i-48.2M-14.6M-18.1M-13.7M-11.5M
Debt Issuance i0260.0K2.3M0458.0K
Debt Repayment i-3.5M-3.3M-2.6M-3.4M-946.0K
Financing Cash Flow i-51.7M-35.4M-18.5M-19.1M-13.9M
Free Cash Flow i75.9M-1.2M26.1M20.2M52.8M
Net Change in Cash i2.1M-46.7M-25.6M-26.7M6.9M

Cash Flow Trend

Faes Farma S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 12.47
Forward P/E 14.62
Price to Book 1.81
Price to Sales 2.43
PEG Ratio 14.62

Profitability Ratios

Profit Margin 19.37%
Operating Margin 18.19%
Return on Equity 14.83%
Return on Assets 6.92%

Financial Health

Current Ratio 2.29
Debt to Equity 11.48
Beta 0.35

Per Share Data

EPS (TTM) €0.34
Book Value per Share €2.34
Revenue per Share €1.75

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
fae1.3B12.471.8114.83%19.37%11.48
Laboratorios 3.0B23.385.5025.01%17.66%22.50
Almirall S.A 2.5B116.001.701.45%2.02%26.47
Laboratorio Reig 229.5M35.251.063.03%1.89%30.99
Labiana Health S.A 28.9M104.006.266.92%0.38%1,378.08
Grifols, S.A 7.5B27.071.574.99%4.00%126.87

Financial data is updated regularly. All figures are in the company's reporting currency.